Skip to main content
. 2022 Apr 2;11(7):1997. doi: 10.3390/jcm11071997

Table 2.

Rate of permanent visual loss associated with GCA before and during the corticosteroid therapy era.

First Author, Year of Publication [Ref] * Study Population Patients with any Degree of Permanent Vision Loss in at Least One Eye Patients with Complete Blindness in at Least One Eye Total Number of Completely Blind Eyes
Total Bilateral Total Bilateral
N N (%) N (%) N (%) N (%) N (%)
Bruce, 1949 [9] 84 34 (40) NA 22 (26) 13 (15) 35 (21)
Birkhead, 1957 [14] 55 21 (38) 7 (13) 13 (24) 5 (9) 18 (16)
53 23 (43) 16 (30) 15 (28) 9 (17) 24 (23)
ϕ 250 121 (48) 92 (37) 67 (27) 54 (22) 121 (24)
Parsons-Smith, 1959 [32] 50 23 (46) NA NA NA 33 (33)
Aiello, 1993 [19] 245 34 (14) 8 (3) 12 (5) 1 (0.4) 14 (6)
Gonzalez-Gay, 2000 [21] 161 24 (15) 8 (5) NA NA NA
Liozon, 2001 [29] 174 23 (13) NA NA 3 (14) NA
Nesher, 2004 [30] 166 32 (19) NA NA NA NA
Salvarini, 2016 [22] 136 26 (19) 7 (5) NA NA NA
Chen, 2016 [35] 245 20 (8) 6 (2) 4 (2) 2 (1) 6 (2)
Saleh, 2016 [36] 840 85 (10) 13 (2) 18 (2) 2 (2) 20 (2)

* Studies published in 1949, 1957, and 1959 include patients seen before the era of corticosteroid therapy. In Birkhead paper: All these patients received corticosteroid therapy after their ocular event, None of these patients received corticosteroid therapy, ϕ From literature review made by the authors: few patients received corticosteroid therapy. NA: not available.